Tumor cells orchestrate the recruitment and activation of stromal cells within the TME and release inflammatory and pro-fibrotic factors, including TGF-B, PDGF, and fibroblast growth factor-2 (FGF-2), amongst others, inducing differentiation of stromal cells into CAFs [13,14]. The gene discussed is FGF2; the disease is neoplasm.